Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000892569-97-000836
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
13
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 1996 10-K405 226857
2 AMENDMENT TO LOAN AGREEMENT EX-4.1(B) 15399
3 LEASE AND OPTION TERMINATION AGREEMENT EX-10.3 5024
4 INDUSTRIAL LEASE EX-10.4 210119
5 AMENDMENT TO LEASE EX-10.4(A) 9299
6 INTELLECTUAL PROPERTY AGREEMENT EX-10.15 24696
7 AMENDMENT TO THE EMPLOYMENT AGREEMENT EX-10.16(A) 13239
8 SUBSIDIARIES OF THE COMPANY EX-22.1 730
9 CONSENT OF PRICE WATERHOUSE LLP EX-23.1 640
10 CONSENT OF DELOITTE & TOUCHE LLP EX-23.2 731
11 CONSENT OF COOPERS & LYBRAND L.L.P. EX-23.3 638
12 FINANCIAL DATA SCHEDULE EX-27.1 2074
13 CONSOLIDATED FINANCIAL STATEMENTS OF SOMERSET EX-99.1 34961
  Complete submission text file 0000892569-97-000836.txt   547175
Mailing Address 311 BONNIE CIRCLE CORONA CA 91720
Business Address 311 BONNIE CIRCLE CORONA CA 91720 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-20045 | Film No.: 97568389
SIC: 2834 Pharmaceutical Preparations